Here are five things to know:
1. Lijun Rong, PhD, University of Illinois at Chicago professor in microbiology and immunology, and his team found that the way Ebola and Marburg enter host cells is through a cell surface receptor.
2. The cell surface receptor is a protein named GPCR, which is part of many biological processes.
3. Because there are thousands of GPCRs in humans, many drugs are already in circulation to combat diseases associated with them.
4. The researchers discovered that 20 GPCR antagonists could hinder Ebola and Marburg viruses from entering host cells.
5. Dr. Rong concluded that there are many existing drugs that may be key in stopping Ebola and Marburg.
More articles on quality & infection control:
Xenex Germ-Zapping Robot cleans up Miami’s Nicklaus Children’s Hospital: 6 points
California could mandate quality, cost transparency for outpatient services; CASA onboard
CMS extends quality reporting deadline to Sept. 1: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.